Drug intelligence / Profile preview

ciclesonide

Development stage
Approved
Lead developer
Takeda
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Inhalation, Intranasal
01

Overview

Ciclesonide is a synthetic, nonhalogenated corticosteroid (glucocorticoid) used primarily as an inhaled or intranasal agent for the prevention and control of asthma and allergic rhinitis symptoms. It acts as a prodrug that is enzymatically converted in the body to its active metabolite, des-ciclesonide (RM1), which has high affinity for the glucocorticoid receptor. By binding to these receptors, ciclesonide exerts potent anti-inflammatory effects through inhibition of leukocyte infiltration, suppression of inflammatory mediators (such as prostaglandins and leukotrienes), and modulation of gene expression involved in immune responses. Ciclesonide is not effective for acute asthma attacks but reduces airway inflammation when used regularly[1][2][3][4][5][6].

Brand names
AlvescoOmnarisZetonnaAservo EquiHaler
Other names
Ciclesonidaciclesonidum
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on ciclesonide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ciclesonide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call